132 related articles for article (PubMed ID: 20172770)
1. Contrast-enhanced ultrasonography in evaluating hepatic metastases from neuroendocrine tumours.
Massironi S; Conte D; Sciola V; Pirola L; Paggi S; Fraquelli M; Ciafardini C; Spampatti MP; Peracchi M
Dig Liver Dis; 2010 Sep; 42(9):635-41. PubMed ID: 20172770
[TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine tumors: characterization with contrast-enhanced ultrasonography.
Dörffel Y; Wermke W
Ultraschall Med; 2008 Oct; 29(5):506-14. PubMed ID: 19241507
[TBL] [Abstract][Full Text] [Related]
3. Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS).
Strobel D; Seitz K; Blank W; Schuler A; Dietrich CF; von Herbay A; Friedrich-Rust M; Bernatik T
Ultraschall Med; 2009 Aug; 30(4):376-82. PubMed ID: 19688669
[TBL] [Abstract][Full Text] [Related]
4. Analysis of neuroendocrine tumour metastases in the liver using contrast enhanced ultrasonography.
Mörk H; Ignee A; Schuessler G; Ott M; Dietrich CF
Scand J Gastroenterol; 2007 May; 42(5):652-62. PubMed ID: 17454888
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal and pancreatic neuroendocrine tumours and carcinomas; a review of rare tumour type.
Siddiqa A; Adel H; Khan SA; Huda F; Sattar A
J Pak Med Assoc; 2019 Apr; 69(4):533-540. PubMed ID: 31000859
[TBL] [Abstract][Full Text] [Related]
6. Differential patterns of contrast enhancement in different focal liver lesions after injection of the microbubble US contrast agent SonoVue.
Quaia E; Degobbis F; Tona G; Mosconi E; Bertolotto M; Pozzi Mucelli R
Radiol Med; 2004 Mar; 107(3):155-65. PubMed ID: 15031681
[TBL] [Abstract][Full Text] [Related]
7. Detection of hepatic metastases with low MI real time contrast enhanced sonography and SonoVue.
Oldenburg A; Hohmann J; Foert E; Skrok J; Hoffmann CW; Frericks B; Wolf KJ; Albrecht T
Ultraschall Med; 2005 Aug; 26(4):277-84. PubMed ID: 16123921
[TBL] [Abstract][Full Text] [Related]
8. Role of contrast-enhanced ultrasound to define prognosis and predict response to biotherapy in pancreatic neuroendocrine tumors.
Del Prete M; Di Sarno A; Modica R; Lassandro F; Giorgio A; Bianco A; Muto M; Gasperi M; Del Prete F; Colao A; Montesarchio V; Faggiano A;
J Endocrinol Invest; 2017 Dec; 40(12):1373-1380. PubMed ID: 28667452
[TBL] [Abstract][Full Text] [Related]
9. Real time contrast enhanced ultrasonography in detection of liver metastases from gastrointestinal cancer.
Piscaglia F; Corradi F; Mancini M; Giangregorio F; Tamberi S; Ugolini G; Cola B; Bazzocchi A; Righini R; Pini P; Fornari F; Bolondi L
BMC Cancer; 2007 Sep; 7():171. PubMed ID: 17767722
[TBL] [Abstract][Full Text] [Related]
10. [Baseline and contrast-enhanced ultrasound of the liver in tumor patients].
Oldenburg A; Albrecht T
Ultraschall Med; 2008 Oct; 29(5):488-98. PubMed ID: 19241505
[TBL] [Abstract][Full Text] [Related]
11. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
Hohmann J; Skrok J; Puls R; Albrecht T
Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
[TBL] [Abstract][Full Text] [Related]
12. Behavior of hepatocellular adenoma on real-time low-mechanical index contrast-enhanced ultrasonography with a second-generation contrast agent.
Ricci P; Cantisani V; D'Onofrio M; Sahani D; Pagliara E; Calliada F; Mehmet E; Sanjeva K; Faccioli N; Pozzi-Mucelli R; D'Ambrosio U; Passariello R
J Ultrasound Med; 2008 Dec; 27(12):1719-26. PubMed ID: 19022997
[TBL] [Abstract][Full Text] [Related]
13. Contrast enhanced ultrasound (CEUS) in the evaluation of liver metastases.
Dănilă M; Popescu A; Sirli R; Sporea I; Martie A; Sendroiu M
Med Ultrason; 2010 Sep; 12(3):233-7. PubMed ID: 21203602
[TBL] [Abstract][Full Text] [Related]
14. Somatostatin receptor scintigraphy in liver metastasis detection from gastroenteropancreatic neuroendocrine tumors.
Schillaci O; Spanu A; Scopinaro F; Falchi A; Danieli R; Marongiu P; Pisu N; Madeddu G; Delle Fave G; Madeddu G
J Nucl Med; 2003 Mar; 44(3):359-68. PubMed ID: 12621001
[TBL] [Abstract][Full Text] [Related]
15. Survival prognostic factors of gastro-enteric-pancreatic neuroendocrine tumors after primary tumor resection in a single tertiary center: Comparison of gastro-enteric and pancreatic locations.
Russolillo N; Vigano' L; Razzore P; Langella S; Motta M; Bertuzzo F; Papotti M; Ferrero A
Eur J Surg Oncol; 2015 Jun; 41(6):751-7. PubMed ID: 25887286
[TBL] [Abstract][Full Text] [Related]
16. Real-time contrast-enhanced ultrasonography of resected and immunohistochemically proven hepatic angiomyolipomas.
Li R; Zhang X; Hua X; Cai P; Zhong H; Guo Y; Ding S; Yan X
Abdom Imaging; 2010 Dec; 35(6):676-82. PubMed ID: 20020286
[TBL] [Abstract][Full Text] [Related]
17. Localization of gastroenteropancreatic tumours by angiography.
Doppman JL; Jensen RT
Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S163-6. PubMed ID: 10604123
[TBL] [Abstract][Full Text] [Related]
18. [Focal liver lesions: clinical usefulness of contrast-enhanced ultrasound in the selection of surgical patients].
Bartolotta TV; Sandonato L; Taibbi A; Latteri S; Soresi M; Lombardo G; Genova C; Latteri MA
Chir Ital; 2009; 61(3):295-307. PubMed ID: 19694231
[TBL] [Abstract][Full Text] [Related]
19. Improved characterisation of histologically proven liver tumours by contrast enhanced ultrasonography during the portal venous and specific late phase of SHU 508A.
Dietrich CF; Ignee A; Trojan J; Fellbaum C; Schuessler G
Gut; 2004 Mar; 53(3):401-5. PubMed ID: 14960524
[TBL] [Abstract][Full Text] [Related]
20. Doppler perfusion index and contrast-enhanced ultrasound in patients with colorectal cancer liver metastases.
Ruan L; Wang S; Zhang J; Ai H; Zhao Q; Yang J; Wei W
Hepatogastroenterology; 2014; 61(129):37-41. PubMed ID: 24895790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
